Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods

Table 4 Insulin sensitivity indices in Group II

Time	0 mo (mean ± SE)	6 mo (mean ± SE)	P value
FPI (uU/mL)	57.33 ± 48.19	71.04 ± 38.88	0.62
HOMA-IR %	3.31 ± 1.11	4.76 ± 0.45	0.223
HOMA-B %	40.75 ± 12.02	46.86 ± 2.62	0.664
Fasting C-peptide (ng/mL)	1.282 ± 0.14	1.896 ± 0.29	0.103
Stimulated C-peptide (ng/mL)	2.63 ± 0.23	3.008 ± 0.26	0.395

HOMA-IR: Homeostasis model assessment insulin resistance index; HOMA-B: Homeostasis model assessment beta cell function.